Juvenescence Ltd 4
4 · AgeX Therapeutics, Inc. · Filed Apr 14, 2022
Insider Transaction Report
Form 4
Juvenescence Ltd
10% Owner
Transactions
- Award
Warrant to Purchase Common Stock
2022-04-14+568,440→ 568,440 totalExercise: $0.88Exp: 2025-04-04→ Common Stock (568,440 underlying)
Footnotes (2)
- [F1]Warrants issued in connection with the draw of loan funds under a Secured Convertible Promissory Note between the issuer and the reporting person.
- [F2]The warrants are exercisable for shares of the issuer's common stock upon issuance.